Race and ethnicity: Risk factors for fungal infections?
Open accessThe DOI matches its Crossref record; 178 of the 179 references it cites were found in a registry or an index; 26 of the 153 sources its claims cite were checked for support.
Abstract
Racial and ethnic identities, largely understood as social rather than biologic constructs, may impact risk for acquiring infectious diseases, including fungal infections. Risk factors may include genetic and immunologic differences such as aberrations in host immune response, host polymorphisms, and epigenomic factors stemming from environmental exposures and underlying social determinants of health. In addition, certain racial and ethnic groups may be predisposed to diseases that increase risk for fungal infections, as well as disparities in healthcare access and health insurance. In this review, we analyzed racial and ethnic identities as risk factors for acquiring fungal infections, as well as race and ethnicity as they relate to risk for severe disease from fungal infections. Risk factors for invasive mold infections such as aspergillosis largely appear related to environmental differences and underlying social determinants of health, although immunologic aberrations and genetic polymorphisms may contribute in some circumstances. Although black and African American individuals appear to be at high risk for superficial and invasive Candida infections and cryptococcosis, the reasons for this are unclear and may be related to underling social determinants of health, disparities in access to healthcare, and other socioeconomic disparities. Risk factors for all the endemic fungi are likely largely related to underlying social determinants of health, socioeconomic, and health disparities, although immunologic mechanisms likely play a role as well, particularly in disseminated coccidioidomycosis.
Overview
CoChat Summary
TL;DR
This narrative review argues that racial and ethnic disparities in fungal infections are largely driven by social determinants of health, environmental/occupational exposures, and healthcare access, though immunogenetic factors may contribute in selected conditions. It finds higher risks for Candida/cryptococcosis in black or African American individuals and for severe coccidioidomycosis in Filipino and black or African American individuals, while aspergillosis and other mold risks are more clearly tied to environment and social factors.
Key findings
- For invasive aspergillosis, evidence for a race association is weak: one study reported 44.6 vs 42.9 cases per 1 million persons in black or African American vs white populations, and another found no association after propensity matching; white cystic fibrosis patients had higher persistent *Aspergillus* colonization (OR 1.74, 95% CI 1.23–2.48, p = 0.002).
- Black or African American individuals had higher invasive candidiasis/candidemia rates: rate 2.3 (95% CI 2.1–2.6) in a 4-state study; in a 9-state study, 12.3 vs 7.0 cases per 100,000 overall. Cryptococcosis mortality was higher in black or African American men (0.19, 95% CI 0.17–0.21) and women (0.06, 95% CI 0.05–0.06) than white men/women (<0.001); 1993 HIV cryptococcosis incidence was 31/1,000 in black vs 23/1,000 in white persons (RR 1.3, 95% CI 1.1–1.6).
- Coccidioidomycosis incidence was higher in American Indian/Alaska Native (17.4) and Hispanic (11.2) than non-Hispanic white (4.1) cases per 100,000; black or African American and Filipino individuals had higher severe/disseminated disease, with odds of disseminated disease as high as 5–10 times white individuals. Histoplasmosis incidence was similar across racial/ethnic categories (range 0.9–1.3 per 100,000), while blastomycosis hospitalization odds were 2–3 times higher for Hispanic white, American Indian/Alaska Native, and Asian persons.
- The review attributes most observed disparities to social determinants, healthcare access/insurance, environmental and occupational exposures, and comorbidities (e.g., HIV, diabetes, hematologic malignancy), with immunogenetic mechanisms such as HLA-A9/HLA-B9, ABO blood type B, HLA-DRB1*1301, and IL-6 polymorphisms possibly contributing in selected endemic mycoses.
Methods
- Narrative review of literature on racial/ethnic differences and risk of invasive fungal infection caused by molds, yeast, and selected endemic mycoses in the United States.
- Synthesis organized by human genomic ancestry/immunology, social determinants of health, and pathogen groups (molds, *Candida*, cryptococcosis, coccidioidomycosis, histoplasmosis, blastomycosis); no systematic search strategy, inclusion criteria, or meta-analysis is described.
Limitations
- Stated: race and ethnicity are social rather than biologic constructs; genetic diversity is greater within racial groups than between them (Lewontin: 85.4% within populations, 8.3% between populations within racial groups, 6.3% between racial groups), complicating causal attribution.
- Stated: race/ethnicity data are often missing or unknown (e.g., coccidioidomycosis race/ethnicity available in <half [39%] of reported cases; histoplasmosis 2019 had data in 859/1,124 [76%]; blastomycosis had 17% unknown race and 26% unknown ethnicity), and observed associations may be confounded by socioeconomic status, healthcare access, insurance, geography, occupation, and environmental exposure.
- Evident: as a narrative review without systematic search or quality appraisal, and with many cited retrospective/surveillance studies, it cannot establish causality; histoplasmosis and blastomycosis are not nationally reportable, limiting generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
14 Valid · 0 Not valid · 83 Not checked · 27 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Numerous single-nucleotide polymorphisms (SNPs) within human TLRs (TLR1 [11], TLR4 [12–15], TLR6 [11], among others) and CLRs (Dectin-1—in particular the Y238X SNP [16–18]; DC-SIGN, mannose receptor and mannose-binding lectin [19–22]) have been identified as risk factors for fungal disease.”
§ Race and ethnicity: Risk factors for fungal infections? > Results > Human genomic ancestry and predisposition to fungal infections
What the sources say
- Not checked yetcites [11] S Kesh, 2005, TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation, Ann N Y Acad Sci source
- Supportedcites [12] PY Bochud, 2008, Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation, N Engl J Med source
This source is one of several citations attached specifically to the TLR4 portion of the sentence, not to the claims about other receptors. Its Results (page unavailable) associate donor TLR4 SNPs and haplotype S4 with increased invasive aspergillosis risk in hematopoietic-cell transplant recipients; the validation study also found an association for S4. (LLM, conf=0.92)
- Not checked yetcites [13] A Carvalho, 2009, Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation, Exp Hematol source
- Supportedcites [14] A Carvalho, 2008, Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis, J Infect Dis source
The citation is offered for the TLR4 portion of the sentence, not the separately cited TLR1, TLR6, or CLR examples. In the Discussion (shown under Materials and Methods in our copy), the paper reports that the TLR4 Asp299Gly SNP was highly associated with chronic cavitary pulmonary aspergillosis, a fungal disease. (LLM, conf=0.92)
- Not checked yetcites [15] CA Van der Graaf, 2006, Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection, Eur Cytokine Netw
- Supportedcites [16] B Ferwerda, 2009, Human dectin-1 deficiency and mucocutaneous fungal infections, N Engl J Med source
The Results (Patients and Pedigree) identify Tyr238X as a dectin-1 SNP in a family affected by recurrent candidiasis and onychomycosis. The Discussion describes it as a possible genetic susceptibility factor for mucosal fungal infection. This supports the dectin-1 example for which this paper is cited, not the other receptors listed in the sentence. (LLM, conf=0.92)
- Not checked yetcites [17] C Cunha, 2010, Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity, Blood source
- Partly supportedcites [18] TS Plantinga, 2009, Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients, Clin Infect Dis sourceExperimental — accuracy not yet measured
This source supports the Dectin-1 Y238X example, not the sentence’s separately cited TLR and other CLR examples. Table 3 (p. 727) shows significantly greater Candida colonization among Y238X carriers, but not a statistically significant increase in candidemia or invasive mold disease. The Discussion says the study could not reach a definitive conclusion about invasive disease risk, so calling Y238X an established risk factor for fungal disease overstates this paper’s finding. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The aforementioned SNPs in IL-6 associated with blastomycosis susceptibility appear to be overrepresented in the Hmong population conveying increased risk [36].”
§ Race and ethnicity: Risk factors for fungal infections? > Results > Human genomic ancestry and predisposition to fungal infections
What the sources say
- Partly supportedcites [36] RM Merkhofer, 2019, Investigation of Genetic Susceptibility to Blastomycosis Reveals Interleukin-6 as a Potential Susceptibility Locus, MBio sourceExperimental — accuracy not yet measured
Our copy supports the population-genetic core: the IL6/AS-IL6 haplotype is 'nearly fixed in WI Hmong' (Results & Discussion, 'IL6 and AS-IL6...', Fig. 2C: AFHmong 0.975 vs AFEAS 0.783 and AFEUR 0.048, and 'these SNPs are not fixed in the WI Hmong at large'). But the source frames the variants only as 'candidate susceptibility variants' (Results, 'Analysis of Hmong blastomycosis patient genomes...'; Fig. 1) from nine patient genomes, and states they are polymorphisms 'that may account for the increased risk of blastomycosis among the WI Hmong' with the explicit hypothesis 'homozygous regulatory variant(s) common to the WI Hmong ... leading to an elevated incidence' (Introduction). The citing sentence converts this into SNPs 'associated with blastomycosis susceptibility ... conveying increased risk', i.e. an established association and conferred risk, which the source hedges and does not demonstrate in humans (its validation is reduced IL-6/IL-17 responses in Hmong donor cells and an IL-6 mouse model). (LLM, conf=0.72)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Furthermore, racial and ethnic differences in diabetes and corresponding complications have been thoroughly discussed in the literature and are clear risk factors for IFIs [53–55].”
§ Race and ethnicity: Risk factors for fungal infections? > Results > Human genomic ancestry and predisposition to fungal infections
What the sources say
- Not checked yetcites [53] AJ Karter, 2002, Ethnic disparities in diabetic complications in an insured population, JAMA source
- Partly supportedcites [54] LC Lanting, 2005, Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review, Diabetes Care sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) reports a review of ethnic differences in diabetes complications, supporting the claim that those differences have been discussed in the literature. The Methods and Variables sections (pages unavailable) define the outcomes as mortality and diabetic complications, not invasive fungal infections. The paper therefore does not support the claim that these differences are risk factors for IFIs. (LLM, conf=0.90)
- Partly supportedcites [55] SH Golden, 2012, Health disparities in endocrine disorders: biological, clinical, and nonclinical factors—an Endocrine Society scientific statement, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
The section on race/ethnic differences in glycemic control (page unavailable) discusses disparities in diabetes control and microvascular complications. It does not identify those differences or complications as risk factors for invasive fungal infections; a search for invasive fungal infections found no supporting passage. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This can be seen in the finding that white CF patients have higher risk for persistent Aspergillus spp. colonization (OR 1.74, 95% CI 1.23 to 2.48, p = 0.002) than black or African American CF patients [83].”
§ Race and ethnicity: Risk factors for fungal infections? > Results > Differences in race/ethnicity in investigated pathogens
What the sources say
- Partly supportedcites [83] G Hong, 2018, Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis., J Cyst Fibros sourceExperimental — accuracy not yet measured
The Results section reports the stated OR, confidence interval, and p-value for white race and persistent Aspergillus isolation. However, the Statistical analysis section defines the race comparison as white versus non-white, not white versus Black or African American patients specifically. The paper also notes in the Discussion that persistent isolation is sometimes termed colonization. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Among HIV-infected persons in a US survey, the incidence of cryptococcosis in 1993 was significantly higher among black or African American persons (31/1,000) than among white persons (23/1,000; relative risk [RR] = 1.3, 95% CI, 1.1 to 1.6) [130].”
§ Race and ethnicity: Risk factors for fungal infections? > Results > Differences in race/ethnicity in investigated pathogens
What the sources say
- Partly supportedcites [130] RA Hajjeh, 1999, Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group, J Infect Dis sourceExperimental — accuracy not yet measured
The “Cryptococcosis in Persons with AIDS” section reports the 1993 racial difference exactly as cited: 31 versus 23 per 1,000, RR 1.3, and 95% CI 1.1–1.6. The rates are presented for persons with AIDS, however, rather than for all HIV-infected persons as the citing sentence implies. (LLM, conf=0.84)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
62 more claims · 4 with their cited sources checked
Create a free account to see all 124 claims and to verify the 127 references still open.
- It may state two separate claims as one. 44
- Probably not a substantial claim. 25
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A higher incidence of candidemia has been reported among older adults, males, and those of black/African-American ethnicity.27,28”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [28]
Experimental — accuracy not yet measured
Citations
Cites
Mapping the Margins: Intersectionality, Identity Politics, and Violence against Women of Color
Crenshaw, K. (1991) · Stanford Law Review · doi:10.2307/1229039 · Cited by 32,792 · cited 1×
“Intersectionality is a framework that helps us understand how socialized categories like race and ethnicity interact with other social factors such as gender, socioeconomic status, occupation, and employment, combine, overlap, and interact to create health inequalities in the US [58,59].”
BackgroundPappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Toward a Field of Intersectionality Studies: Theory, Applications, and Praxis
Cho, S., Crenshaw, K. W., & McCall, L. (2013) · Signs: Journal of Women in Culture and Society · doi:10.1086/669608 · Cited by 4,126 · cited 1×
“Intersectionality is a framework that helps us understand how socialized categories like race and ethnicity interact with other social factors such as gender, socioeconomic status, occupation, and employment, combine, overlap, and interact to create health inequalities in the US [58,59].”
BackgroundEpidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Chiou, C. C., Chu, J. H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432579 · Cited by 3,044 · cited 1×
“5%) [96], while other large epidemiological studies from the US failed to report on racial distribution [97].”
BackgroundPatterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926 · cited 1×
“can cause a spectrum of disease in humans, from non-invasive diseases such as allergic bronchopulmonary aspergillosis that are associated with exacerbation of different underlying lung diseases, to life-threatening infections such as invasive pulmonary aspergillosis, including in those with COVID-19 infection [8,67,68…”
BackgroundSelf-citationPark, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., & Chiller, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e328322ffac · Cited by 2,014
Cornely, O. A., Alastruey-Izquierdo, A., Arenz, D., Chen, S. C. A., Dannaoui, E., Hochhegger, B., Hoenigl, M., Jensen, H. E., Lagrou, K., Lewis, R. E., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30312-3 · Cited by 1,820
Self-citationRomani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793 · cited 2×
“The constitutive mechanisms of immunity are displayed at locations with frequent interaction with fungal pathogens including the mucosa of the respiratory epithelium and the gastrointestinal tract [9].”
BackgroundUpdated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals
Flanagin, A., Frey, T., Christiansen, S. L., & AMA Manual of Style Committee (2021) · JAMA · doi:10.1001/jama.2021.13304 · Cited by 1,615 · cited 2×
“Thus, drawing conclusions between race and ethnicity (social constructs) and human genetics (a biologic construct) is complex and multi-faceted, prompting professional organizations such as the American Medical Association to provide guidance on the use of race, ethnicity, and genomics in medical and scientific litera…”
BackgroundO'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
Smedley, A., & Smedley, B. D. (2005) · American Psychologist · doi:10.1037/0003-066x.60.1.16 · Cited by 1,265
The clinical spectrum of pulmonary aspergillosis
Kosmidis, C., & Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206291 · Cited by 850
Ethnic disparities in diabetic complications in an insured population
Karter, A. J. (2002) · JAMA · doi:10.1001/jama.287.19.2519 · Cited by 840
A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Glocker, E.-O., Hennigs, A., Nabavi, M., Schäffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810719 · Cited by 800 · cited 1×
“Defects in the CARD9 pathway have been found predisposing to chronic mucocutaneous candidiasis [28] and disseminated aspergillosis [29], while polymorphisms in a number of cytokines have also been found to predispose to fungal disease: aspergillosis (IL-1 [30], IL-10 [31,32], IL-15 [32], and IL-23); candidiasis (IL-4)…”
BackgroundHuman dectin-1 deficiency and mucocutaneous fungal infections
Ferwerda, B., Ferwerda, G., Plantinga, T. S., Willment, J. A., van Spriel, A. B., Venselaar, H., Elbers, C. C., Johnson, M. D., Cambi, A., Huysamen, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901053 · Cited by 752 · cited 1×
“The Y238X Dectin-1 polymorphism associated with increased fungal risk is overrepresented in some populations [16] and may be responsible for the increased risk for fungal diseases observed in certain demographic groups.”
BackgroundRecognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex
Hagen, F., Khayhan, K., Theelen, B., Kolecka, A., Polacheck, I., Sionov, E., Falk, R., Parnmen, S., Lumbsch, H. T., & Boekhout, T. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.02.009 · Cited by 687
WHEAT, L. J., CONNOLLY-STRINGFIELD, P. A., BAKER, R. L., CURFMAN, M. F., EADS, M. E., ISRAEL, K. S., NORRIS, S. A., WEBB, D. H., & ZECKEL, M. L. (1990) · Medicine · doi:10.1097/00005792-199011000-00004 · Cited by 651
Taking race out of human genetics
Yudell, M., Roberts, D., DeSalle, R., & Tishkoff, S. (2016) · Science · doi:10.1126/science.aac4951 · Cited by 631
Galgiani, J. N., Ampel, N. M., Blair, J. E., Catanzaro, A., Johnson, R. H., Stevens, D. A., & Williams, P. L. (2005) · Clinical Infectious Diseases · doi:10.1086/496991 · Cited by 603
Garg, D., Muthu, V., Sehgal, I. S., Ramachandran, R., Kaur, H., Bhalla, A., Puri, G. D., Chakrabarti, A., & Agarwal, R. (2021) · Mycopathologia · doi:10.1007/s11046-021-00528-2 · Cited by 579
Epstein, A. M., Ayanian, J. Z., Keogh, J. H., Noonan, S. J., Armistead, N., Cleary, P. D., Weissman, J. S., David-Kasdan, J. A., Carlson, D., Fuller, J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432106 · Cited by 569 · cited 6×
“In conclusion, it is not well established if genetic predispositions are the main driver of increased risk of coccidioidomycosis and certain racial and ethnic groups, although there is a clear increased risk of severe coccidioidomycosis infection in certain racial or ethnic groups, PLOS Pathogens | https://doi.org/10.…”
BackgroundInfluentialCryptococcus: from environmental saprophyte to global pathogen
May, R. C., Stone, N. R. H., Wiesner, D. L., Bicanic, T., & Nielsen, K. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.6 · Cited by 541
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482 · cited 2×
“While mucormycosis occurs worldwide [85], the vast majority of cases are reported from India and neighboring regions, where there is limited racial disparity [86,87].”
BackgroundSelf-citationCryptococcal meningitis: epidemiology, immunology, diagnosis and therapy
Williamson, P. R., Jarvis, J. N., Panackal, A. A., Fisher, M. C., Molloy, S. F., Loyse, A., & Harrison, T. S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.167 · Cited by 480
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India
Patel, A., Agarwal, R., Rudramurthy, S. M., Shevkani, M., Xess, I., Sharma, R., Savio, J., Sethuraman, N., Madan, S., Shastri, P., et al. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2709.210934 · Cited by 479
Hoenigl, M., Salmanton-García, J., Walsh, T. J., Nucci, M., Neoh, C. F., Jenks, J. D., Lackner, M., Sprute, R., Al-Hatmi, A. M. S., Bassetti, M., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30784-2 · Cited by 470
Self-citationToll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation
Bochud, P.-Y., Chien, J. W., Marr, K. A., Leisenring, W. M., Upton, A., Janer, M., Rodrigues, S. D., Li, S., Hansen, J. A., Zhao, L. P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802629 · Cited by 453
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Arastehfar, A., Carvalho, A., van de Veerdonk, F. L., Jenks, J. D., Koehler, P., Krause, R., Cornely, O. A., S. Perlin, D., Lass-Flörl, C., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6020091 · Cited by 421 · cited 1×
“can cause a spectrum of disease in humans, from non-invasive diseases such as allergic bronchopulmonary aspergillosis that are associated with exacerbation of different underlying lung diseases, to life-threatening infections such as invasive pulmonary aspergillosis, including in those with COVID-19 infection [8,67,68…”
BackgroundSelf-citationGolden, S. H., Brown, A., Cauley, J. A., Chin, M. H., Gary-Webb, T. L., Kim, C., Sosa, J. A., Sumner, A. E., & Anton, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2043 · Cited by 405
Disseminated Phaeohyphomycosis: Review of an Emerging Mycosis
Revankar, S. G., Patterson, J. E., Sutton, D. A., Pullen, R., & Rinaldi, M. G. (2002) · Clinical Infectious Diseases · doi:10.1086/338636 · Cited by 395
Lanting, L. C., Joung, I. M. A., Mackenbach, J. P., Lamberts, S. W. J., & Bootsma, A. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2280 · Cited by 386
Mahajan, S., Caraballo, C., Lu, Y., Valero-Elizondo, J., Massey, D., Annapureddy, A. R., Roy, B., Riley, C., Murugiah, K., Onuma, O., et al. (2021) · JAMA · doi:10.1001/jama.2021.9907 · Cited by 368
Epigenetic regulation of the innate immune response to infection
Zhang, Q., & Cao, X. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0151-6 · Cited by 366 · cited 1×
“These social determinants of health may lead to alterations in patient DNA methylation, chromatin remodeling, histone modification, and regulatory RNA changes and subsequently alter the patient immune response [48].”
BackgroundNecrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011
Neblett Fanfair, R., Benedict, K., Bos, J., Bennett, S. D., Lo, Y.-C., Adebanjo, T., Etienne, K., Deak, E., Derado, G., Shieh, W.-J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204781 · Cited by 360 · cited 2×
“Outbreaks of mucormycosis outside of India are often associated with natural disasters [90] such as hurricanes [91,92], tsunamis [91], or floodings [93], primarily affecting socially disadvantaged populations living in affected areas.”
BackgroundA model of disparities: risk factors associated with COVID-19 infection
Rozenfeld, Y., Beam, J., Maier, H., Haggerson, W., Boudreau, K., Carlson, J., & Medows, R. (2020) · International Journal for Equity in Health · doi:10.1186/s12939-020-01242-z · Cited by 358
Invasive Non- Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006
Park, B. J., Pappas, P. G., Wannemuehler, K. A., Alexander, B. D., Anaissie, E. J., Andes, D. R., Baddley, J. W., Brown, J. M., Brumble, L. M., Freifeld, A. G., et al. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110087 · Cited by 321
Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases.
Smith, C. E., & Beard, R. R. (1946) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.36.12.1394 · Cited by 313
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation
Cunha, C., Aversa, F., Lacerda, J. F., Busca, A., Kurzai, O., Grube, M., Löffler, J., Maertens, J. A., Bell, A. S., Inforzato, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1211161 · Cited by 307
Cunha, C., Di Ianni, M., Bozza, S., Giovannini, G., Zagarella, S., Zelante, T., D'Angelo, C., Pierini, A., Pitzurra, L., Falzetti, F., et al. (2010) · Blood · doi:10.1182/blood-2010-04-279307 · Cited by 286
Coccidioidomycosis as a common cause of community-acquired pneumonia
Valdivia, L., Nix, D., Wright, M., Lindberg, E., Fagan, T., Lieberman, D., Stoffer, T., Ampel, N. M., & Galgiani, J. N. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1206.060028 · Cited by 285
Hajjeh, R. A., Conn, L. A., Stephens, D. S., Baughman, W., Hamill, R., Graviss, E., Pappas, P. G., Thomas, C., Reingold, A., Rothrock, G., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314606 · Cited by 275
Brizendine, K. D., Baddley, J. W., & Pappas, P. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060431 · Cited by 265
Hebart, H., Bollinger, C., Fisch, P., Sarfati, J., Meisner, C., Baur, M., Loeffler, J., Monod, M., Latgé, J.-P., & Einsele, H. (2002) · Blood · doi:10.1182/blood-2002-01-0265 · Cited by 257 · cited 1×
“Extensive investigation of T cells over the last 3 decades has further enhanced our understanding in their role in providing protective immunity [43].”
BackgroundPolymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis
Carvalho, A., Pasqualotto, A. C., Pitzurra, L., Romani, L., Denning, D. W., & Rodrigues, F. (2008) · The Journal of Infectious Diseases · doi:10.1086/526500 · Cited by 255
Plantinga, T. S., van der Velden, W. J. F. M., Ferwerda, B., van Spriel, A. B., Adema, G., Feuth, T., Donnelly, J. P., Brown, G. D., Kullberg, B., Blijlevens, N. M. A., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/604714 · Cited by 247
Rosenstein, N. E., Emery, K. W., Werner, S. B., Kao, A., Johnson, R., Rogers, D., Vugia, D., Reingold, A., Talbot, R., Plikaytis, B. D., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/319203 · Cited by 232
Cryptococcus gattii in the United States: Clinical Aspects of Infection With an Emerging Pathogen
Harris, J. R., Lockhart, S. R., Debess, E., Marsden-Haug, N., Goldoft, M., Wohrle, R., Lee, S., Smelser, C., Park, B., & Chiller, T. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir723 · Cited by 219
Malik, U., Cheema, H., Kandikatla, R., Ahmed, Y., & Chakrala, K. (2017) · Case Reports in Gastroenterology · doi:10.1159/000456655 · Cited by 213
KESH, S., MENSAH, N. Y., PETERLONGO, P., JAFFE, D., HSU, K., VAN DEN BRINK, M., O'REILLY, R., PAMER, E., SATAGOPAN, J., & PAPANICOLAOU, G. A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1358.012 · Cited by 208 · cited 1×
“Numerous single-nucleotide polymorphisms (SNPs) within human TLRs (TLR1 [11], TLR4 [12–15], TLR6 [11], among others) and CLRs (Dectin-1—in particular the Y238X SNP [16–18]; DC-SIGN, mannose receptor and mannose-binding lectin [19–22]) have been identified as risk factors for fungal disease.”
BackgroundCoccidioidomycosis: host response and vaccine development
Cox, R. A., & Magee, D. M. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.804-839.2004 · Cited by 205 · cited 1×
“blood type B have been associated with more severe coccidioidomycosis infection, although it is unclear if there is a causal association or if this association is merely due to an increased proportion of these phenotypes in Filipino and black or African American individuals [44,45].”
BackgroundRudramurthy, S. M., Hoenigl, M., Meis, J. F., Cornely, O. A., Muthu, V., Gangneux, J. P., Perfect, J., Chakrabarti, A., & ISHAM, E. A. (2021) · Mycoses · doi:10.1111/myc.13335 · Cited by 205 · cited 1×
“In India, a steep increase of mucormycosis cases was observed during the COVID-19 pandemic [88,89], driven by specific immunological mechanisms that predispose COVID-19 patients to mucormycosis [87], as well as overuse of systemic corticosteroids and an increase in the population with undiagnosed or uncontrolled diabe…”
BackgroundSelf-citationInvasive fungal infections after natural disasters
Benedict, K., & Park, B. J. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2003.131230 · Cited by 199 · cited 1×
“Outbreaks of mucormycosis outside of India are often associated with natural disasters [90] such as hurricanes [91,92], tsunamis [91], or floodings [93], primarily affecting socially disadvantaged populations living in affected areas.”
BackgroundEpidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy
Cotch, M. F., Hillier, S. L., Gibbs, R. S., & Eschenbach, D. A. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)80028-8 · Cited by 198
Toda, M., Williams, S. R., Berkow, E. L., Farley, M. M., Harrison, L. H., Bonner, L., Marceaux, K. M., Hollick, R., Zhang, A. Y., Schaffner, W., et al. (2019) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6808a1 · Cited by 198
Improvement in the outcome of invasive fusariosis in the last decade
Nucci, M., Marr, K. A., Vehreschild, M. J. G. T., de Souza, C. A., Velasco, E., Cappellano, P., Carlesse, F., Queiroz-Telles, F., Sheppard, D. C., Kindo, A., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12409 · Cited by 197
Self-citationRisk Factors for Disseminated or Fatal Histoplasmosis: Analysis of a Large Urban Outbreak
WHEAT, L. J., SLAMA, T. G., NORTON, J. A., KOHLER, R. B., EITZEN, H. E., FRENCH, M. L. V., & SATHAPATAYAVONGS, B. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-2-159 · Cited by 196
Aspergillosis Complicating Severe Coronavirus Disease
Marr, K. A., Platt, A., Tornheim, J. A., Zhang, S. X., Datta, K., Cardozo, C., & Garcia-Vidal, C. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2701.202896 · Cited by 190
Thompson, G. R., & Young, J.-A. H. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2027424 · Cited by 184 · cited 4×
“The host immune response must simultaneously kill invading fungal organisms, while minimizing the surrounding inflammatory reaction and maintaining immune homeostasis [8].”
BackgroundInfluentialSelf-citationAndes, D. R., Safdar, N., Baddley, J. W., Alexander, B., Brumble, L., Freifeld, A., Hadley, S., Herwaldt, L., Kauffman, C., Lyon, G. M., et al. (2016) · Transplant Infectious Disease · doi:10.1111/tid.12613 · Cited by 182
Blastomycosis in immunocompromised patients.
Pappas, P. G., Threlkeld, M. G., Bedsole, G. D., Cleveland, K. O., Gelfand, M. S., & Dismukes, W. E. (1993) · Medicine · doi:10.1097/00005792-199309000-00003 · Cited by 177
Genome Sequences Reveal Cryptic Speciation in the Human Pathogen Histoplasma capsulatum
Sepúlveda, V. E., Márquez, R., Turissini, D. A., Goldman, W. E., & Matute, D. R. (2017) · mBio · doi:10.1128/mbio.01339-17 · Cited by 175
Improvements in diagnosis of histoplasmosis.
Wheat, L. J. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.11.1207 · Cited by 172
The social construction of race: biracial identity and vulnerability to stereotypes
Shih, M., Bonam, C., Sanchez, D., & Peck, C. (2007) · Cultural Diversity & Ethnic Minority Psychology · doi:10.1037/1099-9809.13.2.125 · Cited by 171
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency
Rieber, N., Gazendam, R. P., Freeman, A. F., Hsu, A. P., Collar, A. L., Sugui, J. A., Drummond, R. A., Rongkavilit, C., Hoffman, K., Henderson, C., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89890 · Cited by 171 · cited 1×
“Defects in the CARD9 pathway have been found predisposing to chronic mucocutaneous candidiasis [28] and disseminated aspergillosis [29], while polymorphisms in a number of cytokines have also been found to predispose to fungal disease: aspergillosis (IL-1 [30], IL-10 [31,32], IL-15 [32], and IL-23); candidiasis (IL-4)…”
BackgroundGeoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation
Panackal, A. A., Li, H., Kontoyiannis, D. P., Mori, M., Perego, C. A., Boeckh, M., & Marr, K. A. (2010) · Clinical Infectious Diseases · doi:10.1086/652761 · Cited by 169 · cited 2×
“Climate factors play a role in the airborne spread of the spores that can vary based on regions and seasons [73] and more importantly, can result in selection pressure for antifungal resistant ones, especially in regions that have exposure to azoles pesticides [74].”
BackgroundRacial and ethnic disparities in hematologic malignancies
Kirtane, K., & Lee, S. J. (2017) · Blood · doi:10.1182/blood-2017-04-778225 · Cited by 168 · cited 1×
“Significant racial and ethnic disparities in the incidence and survival of hematologic malignancies have also been documented [51,52].”
BackgroundBreton, C. V., Landon, R., Kahn, L. G., Enlow, M. B., Peterson, A. K., Bastain, T., Braun, J., Comstock, S. S., Duarte, C. S., Hipwell, A., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02316-6 · Cited by 165 · cited 1×
“Recent work analyzing the association between environmental exposure, psychosocial stressors, and nutrition has found these important influences in the patient genome and epigenome over multiple generations [47].”
BackgroundBurden of Candidemia in the United States, 2017
Tsay, S. V., Mu, Y., Williams, S., Epson, E., Nadle, J., Bamberg, W. M., Barter, D. M., Johnston, H. L., Farley, M. M., Harb, S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa193 · Cited by 163
Coccidioidomycosis in renal replacement therapy
Cohen, I. M. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340160069017 · Cited by 163
van der Graaf, C. A. A., Netea, M. G., Morré, S. A., den Heijer, M., Verweij, P. E., van der Meer, J. W. M., & Kullberg, B. J. (2006) · PubMed · Cited by 160
Seidel, D., Meißner, A., Lackner, M., Piepenbrock, E., Salmanton-García, J., Stecher, M., Mellinghoff, S., Hamprecht, A., Durán Graeff, L., Köhler, P., et al. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2018.1514366 · Cited by 159
Candida vaginitis: Self-Reported Incidence and Associated Costs
Foxman, B., Barlow, R., Dʼarcy, H., Gillespie, B., & Sobel, J. D. (2000) · Sexually Transmitted Diseases · doi:10.1097/00007435-200004000-00009 · Cited by 158
Risk Factors for Vulvovaginal Candidiasis: A Case- Control Study among University Students
Geiger, A. M., & Foxman, B. (1996) · Epidemiology · doi:10.1097/00001648-199603000-00013 · Cited by 154
Plasminogen Alleles Influence Susceptibility to Invasive Aspergillosis
Zaas, A. K., Liao, G., Chien, J. W., Weinberg, C., Shore, D., Giles, S. S., Marr, K. A., Usuka, J., Burch, L. H., Perera, L., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000101 · Cited by 153 · cited 1×
“Plasminogen also appears to be a key regulator in susceptibility to aspergillosis [42].”
BackgroundBrown, E. M., McTaggart, L. R., Zhang, S. X., Low, D. E., Stevens, D. A., & Richardson, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059237 · Cited by 148
Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi.
Lemos, L. B., Guo, M., & Baliga, M. (2000) · Annals of Diagnostic Pathology · doi:10.1053/adpa.2000.20755 · Cited by 134
Sex disparities in COVID-19 outcomes in the United States: Quantifying and contextualizing variation
Danielsen, A. C., Lee, K. M. N., Boulicault, M., Rushovich, T., Gompers, A. D., Tarrant, A., Reiches, M. W., Shattuck‐Heidorn, H., Miratrix, L. W., & Richardson, S. S. (2022) · Social Science & Medicine · doi:10.1016/j.socscimed.2022.114716 · Cited by 132 · cited 1×
“For example, Coronavirus Disease 2019 (COVID-19) mortality data initially pointed to biologic sex differences as men died at higher rates than women, but these differences were moderated by race, ethnicity, geographic location within the US, and time [60].”
BackgroundEpidemiology of blastomycosis in a region of high endemicity in north central Wisconsin
Baumgardner, D. J., Buggy, B. P., Mattson, B. J., Burdick, J. S., & Ludwig, D. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.4.629 · Cited by 131
Babula, O., Lazdane, G., Kroica, J., Linhares, I. M., Ledger, W. J., & Witkin, S. S. (2005) · Clinical Infectious Diseases · doi:10.1086/429246 · Cited by 130 · cited 1×
“Defects in the CARD9 pathway have been found predisposing to chronic mucocutaneous candidiasis [28] and disseminated aspergillosis [29], while polymorphisms in a number of cytokines have also been found to predispose to fungal disease: aspergillosis (IL-1 [30], IL-10 [31,32], IL-15 [32], and IL-23); candidiasis (IL-4)…”
BackgroundAnti–IFN-γ autoantibodies underlie disseminated Talaromyces marneffei infections
Guo, J., Ning, X.-Q., Ding, J.-Y., Zheng, Y.-Q., Shi, N.-N., Wu, F.-Y., Lin, Y.-K., Shih, H.-P., Ting, H.-T., Liang, G., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190502 · Cited by 130 · cited 1×
“Polymorphisms within the interferon-γ (INF-γ) gene [39] and its receptor have also been associated with fungal disease risk, and auto-antibodies to IFNγ have similarly seen an increased rate of fungal infections and may be more frequent in some patient groups [40].”
BackgroundInfluence of Interleukin‐10 on Aspergillus fumigatus Infection in Patients with Cystic Fibrosis
Brouard, J., Knauer, N., Boelle, P., Corvol, H., Henrion‐Caude, A., Flamant, C., Bremont, F., Delaisi, B., Duhamel, J., Marguet, C., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429964 · Cited by 120
Coronavirus disease 2019 (COVID-19) mortality and neighborhood characteristics in Chicago
Bryan, M. S., Sun, J., Jagai, J. S., Horton, D. E., Montgomery, A., Sargis, R. M., & Argos, M. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.10.011 · Cited by 118
Sex Disparities in COVID-19 Mortality Vary Across US Racial Groups
Rushovich, T., Boulicault, M., Chen, J. T., Danielsen, A. C., Tarrant, A., Richardson, S. S., & Shattuck‐Heidorn, H. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06699-4 · Cited by 117
Maraví-Poma, E., Rodrı́guez-Tudela, J. L., de Jalón, J. G., Manrique-Larralde, A., Torroba, L., Urtasun, J., Salvador, B. B., Montes, M., Mellado, E., Rodríguez-Albarrán, F., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2132-1 · Cited by 115 · cited 1×
“Other outbreaks of mucormycosis have been associated with contaminated hospital products such as linen or a wooden spatula [94,95].”
BackgroundLeal, S. M., Roy, S., Vareechon, C., Carrion, S. D., Clark, H., Lopez-Berges, M. S., diPietro, A., Schrettl, M., Beckmann, N., Redl, B., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003436 · Cited by 111 · cited 1×
“, defensins) and proteases, and attempt to sequester iron availability in response to fungal invasion [8,41].”
BackgroundWoods, C. W., McRill, C., Plikaytis, B. D., Rosenstein, N. E., Mosley, D., Boyd, D., England, B., Perkins, B. A., Ampel, N. M., & Hajjeh, R. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315401 · Cited by 107
Multistate Epidemiology of Histoplasmosis, United States, 2011–20141
Armstrong, P. A., Jackson, B. R., Haselow, D., Fields, V., Ireland, M., Austin, C., Signs, K., Fialkowski, V., Patel, R., Ellis, P., et al. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2403.171258 · Cited by 105
Carvalho, A., Cunha, C., Carotti, A., Aloisi, T., Guarrera, O., Di Ianni, M., Falzetti, F., Bistoni, F., Aversa, F., Pitzurra, L., et al. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.06.004 · Cited by 104
Mezger, M., Steffens, M., Beyer, M., Manger, C., Eberle, J., Toliat, M.-R., Wienker, T. F., Ljungman, P., Hebart, H., Dornbusch, H. J., et al. (2008) · Blood · doi:10.1182/blood-2007-05-090928 · Cited by 103 · cited 1×
“Neutrophils are well known for their role in providing protection against invading fungal pathogens and their recruitment is dependent upon chemokine release [26], and polymorphisms resulting in CXCL10 expression changes have been found associated with aspergillosis [27].”
BackgroundGalgiani, J. N., Ampel, N. M., Blair, J. E., Catanzaro, A., Geertsma, F., Hoover, S. E., Johnson, R. H., Kusne, S., Lisse, J., MacDonald, J. D., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw538 · Cited by 102
The epidemiology of blastomycosis in Illinois and factors associated with death
Dworkin, M. S., Duckro, A. N., Proia, L., Semel, J. D., & Huhn, G. (2005) · Clinical Infectious Diseases · doi:10.1086/498152 · Cited by 100
Influence of host genetics on the severity of coccidioidomycosis
Louie, L., Ng, S., Hajjeh, R., Johnson, R., Vugia, D., Werner, S. B., Talbot, R., & Klitz, W. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0505.990508 · Cited by 99 · cited 1×
“In addition, in another study the HLA class II-DRB11301 allele was a marker for disseminated coccidioidomycosis, independent of race or ethnicity [46].”
ResultJenks, J. D., Reed, S. L., Seidel, D., Koehler, P., Cornely, O. A., Mehta, S. R., & Hoenigl, M. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.08.005 · Cited by 99
Self-citationGranell, M., Urbano-Ispizúa, Á., Suárez, B., Rovira, M., Fernández‐Avilés, F., Martínez, C., Ortega, M., Uriburu, C., Gayà, A., Roncero, J. M., et al. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.06.005 · Cited by 98
Vallabhaneni, S., Benedict, K., Derado, G., & Mody, R. K. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw268 · Cited by 98
Socioeconomic factors in the diagnosis of allergic fungal rhinosinusitis.
Wise, S. K., Ghegan, M. D., Gorham, E., & Schlosser, R. J. (2008) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2007.10.020 · Cited by 97 · cited 1×
“, has a higher incidence in the southern regions of the US, especially among black or African American compared to white populations living in these regions [84], which signals environmental and possibly socioeconomic factors related to the development of this disease.”
BackgroundEvaluation of Racial and Ethnic Disparities in Cardiac Transplantation
Chouairi, F., Fuery, M., Clark, K. A., Mullan, C. W., Stewart, J., Caraballo, C., Clarke, J. D., Sen, S., Guha, A., Ibrahim, N. E., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.021067 · Cited by 96 · cited 1×
“Racial minorities suffer from hurdles accessing healthcare, including accessing solid and hematopoietic transplants [75,76]; therefore, there may be a hypothetical increase in the incidence of IA among the white population who receive these procedures more often.”
BackgroundHealth Disparities in Kidney Transplantation for African Americans
Harding, K., Baye, T. M., Pham, P. T., Waterman, A. D., Webb, F. J., Vassalotti, J. A., & Nicholas, S. B. (2017) · American Journal of Nephrology · doi:10.1159/000479480 · Cited by 91 · cited 1×
“Racial minorities suffer from hurdles accessing healthcare, including accessing solid and hematopoietic transplants [75,76]; therefore, there may be a hypothetical increase in the incidence of IA among the white population who receive these procedures more often.”
BackgroundA large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering
Roy, M., Benedict, K., Deak, E., Kirby, M. A., McNiel, J. T., Sickler, C. J., Eckardt, E., Marx, R. K., Heffernan, R. T., Meece, J. K., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit366 · Cited by 90
Mycotic Infections Acquired outside Areas of Known Endemicity, United States
Benedict, K., Thompson, G. R., Deresinski, S., & Chiller, T. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2111.141950 · Cited by 89
Self-citationCryptococcus gattii: An Emerging Cause of Fungal Disease in North America
Dixit, A., Carroll, S. F., & Qureshi, S. T. (2009) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2009/840452 · Cited by 89
Climate Change and the Epidemiology of Infectious Diseases in the United States
Edelson, P. J., Harold, R., Ackelsberg, J., Duchin, J. S., Lawrence, S. J., Manabe, Y. C., Zahn, M., & LaRocque, R. C. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac697 · Cited by 88
Donders, G., Babula, O., Bellen, G., Linhares, I., & Witkin, S. (2008) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01830.x · Cited by 87
Fisher, C. E., Hohl, T. M., Fan, W., Storer, B. E., Levine, D. M., Zhao, L. P., Martin, P. J., Warren, E. H., Boeckh, M., & Hansen, J. A. (2017) · Blood · doi:10.1182/blood-2016-10-743294 · Cited by 87
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
Thompson III, G. R., Cornely, O. A., Pappas, P. G., Patterson, T. F., Hoenigl, M., Jenks, J. D., Clancy, C. J., & Nguyen, M. H. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa242 · Cited by 85 · cited 1×
“can cause a spectrum of disease in humans, from non-invasive diseases such as allergic bronchopulmonary aspergillosis that are associated with exacerbation of different underlying lung diseases, to life-threatening infections such as invasive pulmonary aspergillosis, including in those with COVID-19 infection [8,67,68…”
BackgroundSelf-citationSainz, J., Pérez, E., Gómez-Lopera, S., & Jurado, M. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9197-0 · Cited by 84 · cited 1×
“Defects in the CARD9 pathway have been found predisposing to chronic mucocutaneous candidiasis [28] and disseminated aspergillosis [29], while polymorphisms in a number of cytokines have also been found to predispose to fungal disease: aspergillosis (IL-1 [30], IL-10 [31,32], IL-15 [32], and IL-23); candidiasis (IL-4)…”
BackgroundTreatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance® registry
Horn, D. L., Freifeld, A. G., Schuster, M. G., Azie, N. E., Franks, B., & Kauffman, C. A. (2014) · Mycoses · doi:10.1111/myc.12212 · Cited by 83
Oral manifestations of HIV in a southeast USA population
Patton, L., McKaig, R., Strauss, R., & Jr, J. E. (1998) · Oral Diseases · doi:10.1111/j.1601-0825.1998.tb00274.x · Cited by 83
Cytokine profiling of pulmonary aspergillosis
Sambatakou, H., Pravica, V., Hutchinson, I. V., & Denning, D. W. (2006) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2006.00616.x · Cited by 83 · cited 3×
“Risk factors for aspergillosis and other invasive mold infections largely appear related to environmental differences and underlying social determinants of health, although immunologic aberrations and genetic polymorphisms may play a role in some circumstances, such as defects in the CARD9 pathway and polymorphisms su…”
BackgroundSurveillance for Coccidioidomycosis—United States, 2011–2017.
Benedict, K., McCotter, O. Z., Brady, S., Komatsu, K., Sondermeyer, G. L., Cooksey, Nguyen, A., Jain, S., Vugia, D. J., & Jackson, B. R. (2019) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6807a1 · Cited by 82
Let’s talk about sex characteristics—as a risk factor for invasive fungal diseases.
Egger, M., Hoenigl, M., Thompson, G. R., Carvalho, A., & Jenks, J. D. (2022) · Mycoses · doi:10.1111/myc.13449 · Cited by 82 · cited 3×
“Healthcare accessibility has previously been discussed by our team as a plausible explanation of gender disparities in invasive fungal infections [1].”
BackgroundInfluentialSelf-citationCheng, V. C., Chen, J. H.-K., Wong, S. C. Y., Leung, S. S. M., So, S. Y.-C., Lung, D. C., Lee, W.-M., Trendell-Smith, N. J., Chan, W.-M., Ng, D., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ1006 · Cited by 82 · cited 1×
“Other outbreaks of mucormycosis have been associated with contaminated hospital products such as linen or a wooden spatula [94,95].”
BackgroundClinical Findings for Fungal Infections Caused by Methylprednisolone Injections
Chiller, T. M., Roy, M., Nguyen, D. B., Guh, A. Y., Malani, A. N., Latham, R. H., Peglow, S., Kerkering, T., Kaufman, D., McFadden, J. D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304879 · Cited by 82
Coccidioidomycosis-associated Deaths, United States, 1990–2008
Huang, J. Y., Bristow, B., Shafir, S., & Sorvillo, F. (2012) · Emerging Infectious Diseases · doi:10.3201/eid1811.120752 · Cited by 81
Sainz, J., Pérez, E., Hassan, L., Moratalla, A., Romero, A., Collado, M. D., & Jurado, M. (2007) · Human Immunology · doi:10.1016/j.humimm.2006.10.011 · Cited by 81 · cited 1×
“Polymorphisms within the tumor necrosis factor-α (TNF-α) gene [32] and its receptors [37,38] have also been associated with susceptibility to aspergillosis.”
BackgroundMonson, R. S., Kemerley, P., Walczak, D., Benedetti, E., Oberholzer, J., & Danielson, K. K. (2014) · Transplantation · doi:10.1097/tp.0000000000000271 · Cited by 81 · cited 6×
“In conclusion, it is not well established if genetic predispositions are the main driver of increased risk of coccidioidomycosis and certain racial and ethnic groups, although there is a clear increased risk of severe coccidioidomycosis infection in certain racial or ethnic groups, PLOS Pathogens | https://doi.org/10.…”
BackgroundInfluentialJenks, J. D., Seidel, D., Cornely, O. A., Chen, S., van Hal, S., Kauffman, C., Miceli, M. H., Heinemann, M., Christner, M., Jover Sáenz, A., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.01.012 · Cited by 80
Self-citationInvasive Fungal Infections in the Intensive Care Unit
Ostrosky-Zeichner, L., & Al-Obaidi, M. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.05.005 · Cited by 76
Self-citationKaur, S., Gupta, V. K., Shah, A., Thiel, S., Sarma, P. U., & Madan, T. (2006) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03007.x · Cited by 75
Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis—United States, 2019.
Smith, D. J., Williams, S. L., Endemic Mycoses State Partners Group, Benedict, K. M., Jackson, B. R., Toda, M., Endemic Mycoses State Partners Group, Adame, G., Rothfeldt, L., Cooksey, G. S., et al. (2022) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7107a1 · Cited by 75
Revankar, S. G., Baddley, J. W., Chen, S. C. A., Kauffman, C. A., Slavin, M., Vazquez, J. A., Seas, C., Morris, M. I., Nguyen, M. H., Shoham, S., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx200 · Cited by 67
Self-citationIsolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA
Hurst, S. F., Berkow, E. L., Stevenson, K. L., Litvintseva, A. P., & Lockhart, S. R. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx168 · Cited by 66 · cited 2×
“Climate factors play a role in the airborne spread of the spores that can vary based on regions and seasons [73] and more importantly, can result in selection pressure for antifungal resistant ones, especially in regions that have exposure to azoles pesticides [74].”
BackgroundCoccidioidomycosis in African Americans
Ruddy, B. E., Mayer, A. P., Ko, M. G., Labonte, H. R., Borovansky, J. A., Boroff, E. S., & Blair, J. E. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0423 · Cited by 65 · cited 1×
“blood type B have been associated with more severe coccidioidomycosis infection, although it is unclear if there is a causal association or if this association is merely due to an increased proportion of these phenotypes in Filipino and black or African American individuals [44,45].”
BackgroundJenks, J. D., Seidel, D., Cornely, O. A., Chen, S., van Hal, S., Kauffman, C., Miceli, M. H., Heinemann, M., Christner, M., Jover Sáenz, A., et al. (2020) · Mycoses · doi:10.1111/myc.13067 · Cited by 65
Self-citationZilberberg, M. D., Nathanson, B. H., Harrington, R., Spalding, J. R., & Shorr, A. F. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy181 · Cited by 62 · cited 2×
“there was no statistical difference in the incidence of IA in different parts of the US after implementing propensity matching [81].”
BackgroundRegional Analysis of Coccidioidomycosis Incidence—California, 2000-2018
Sondermeyer Cooksey, G. L., Nguyen, A., Vugia, D., & Jain, S. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6948a4 · Cited by 60
Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis.
Hong, G., Psoter, K. J., Jennings, M. T., Merlo, C. A., Boyle, M. P., Hadjiliadis, D., Kawut, S. M., & Lechtzin, N. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.01.008 · Cited by 59 · cited 1×
“002) than black or African American CF patients [83].”
BackgroundDo high MICs predict the outcome in invasive fusariosis?
Nucci, M., Jenks, J. D., Thompson, G. R., Hoenigl, M., dos Santos, M. C., Forghieri, F., Rico, J. C., Bonuomo, V., López-Soria, L., Lass‐Flörl, C., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa516 · Cited by 58
Self-citationFerreira, O. G., Cardoso, S. V., Borges, A. S., Ferreira, M. S., & Loyola, A. M. (2002) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1067/moe.2002.122588 · Cited by 57
Sainz, J., Salas-Alvarado, I., López-Fernández, E., Olmedo, C., Comino, A., García, F., Blanco, A., Gómez-Lopera, S., Oyonarte, S., Bueno, P., et al. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300205 · Cited by 56 · cited 1×
“Polymorphisms within the tumor necrosis factor-α (TNF-α) gene [32] and its receptors [37,38] have also been associated with susceptibility to aspergillosis.”
BackgroundOropharyngeal histoplasmosis: report of eleven cases and review of the literature.
Antonello, V. S., Zaltron, V. F., Vial, M., Oliveira, F. M. D., & Severo, L. C. (2011) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822011000100007 · Cited by 55
Pope, R., Wu, J., & Boone, C. (2016) · Environmental Management · doi:10.1007/s00267-016-0741-z · Cited by 54
Choi, E. H., Foster, C. B., Taylor, J. G., Erichsen, H. C., Chen, R. A., Walsh, T. J., Anttila, V., Ruutu, T., Palotie, A., & Chanock, S. J. (2003) · The Journal of Infectious Diseases · doi:10.1086/368345 · Cited by 52 · cited 1×
“Defects in the CARD9 pathway have been found predisposing to chronic mucocutaneous candidiasis [28] and disseminated aspergillosis [29], while polymorphisms in a number of cytokines have also been found to predispose to fungal disease: aspergillosis (IL-1 [30], IL-10 [31,32], IL-15 [32], and IL-23); candidiasis (IL-4)…”
BackgroundIncidence and trends of blastomycosis-associated hospitalizations in the United States.
Seitz, A. E., Younes, N., Steiner, C. A., & Prevots, D. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105466 · Cited by 51
Epigenetic Mechanisms Governing Innate Inflammatory Responses
Perkins, D. J., Patel, M. C., Blanco, J. C. G., & Vogel, S. N. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0003 · Cited by 51 · cited 1×
“The epigenetic changes may alter cell type-specific and temporal gene expression ultimately resulting alterations of individual patient risk for fungal infections [49].”
BackgroundXu, J. J., Chen, J. T., Belin, T. R., Brookmeyer, R., Suchard, M. A., & Ramirez, C. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18062921 · Cited by 50
The Complex Immunology of Human Coccidioidomycosis
Ampel, N. M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1406.032 · Cited by 49
Blastomycosis mortality rates, United States, 1990–2010
Khuu, D., Shafir, S., Bristow, B., & Sorvillo, F. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2011.131175 · Cited by 47
Factors Influencing Distribution of Coccidioides immitis in Soil, Washington State, 2016.
Chow, N. A., Kangiser, D., Gade, L., McCotter, O. Z., Hurst, S., Salamone, A., Wohrle, R., Clifford, W., Kim, S., Salah, Z., et al. (2021) · mSphere · doi:10.1128/msphere.00598-21 · Cited by 46
Twenty years of evolving trends in racial disparities for adult kidney transplant recipients
Taber, D. J., Gebregziabher, M., Hunt, K. J., Srinivas, T. R., Chavin, K. D., Baliga, P. K., & Egede, L. E. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.029 · Cited by 46 · cited 1×
“Similarly, black or African Americans experience a longer time on the renal transplant waiting list [77] and are less likely to complete a kidney transplant compared to white Americans [78,79].”
BackgroundEstimating severe coccidioidomycosis in California
Flaherman, V. J., Hector, R., & Rutherford, G. W. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1307.061480 · Cited by 44
Lupiañez, C. B., Canet, L. M., Carvalho, A., Alcazar-Fuoli, L., Springer, J., Lackner, M., Segura-Catena, J., Comino, A., Olmedo, C., Ríos, R., et al. (2016) · Infection and Immunity · doi:10.1128/iai.01359-15 · Cited by 42 · cited 1×
“Polymorphisms within the interferon-γ (INF-γ) gene [39] and its receptor have also been associated with fungal disease risk, and auto-antibodies to IFNγ have similarly seen an increased rate of fungal infections and may be more frequent in some patient groups [40].”
BackgroundErythema nodosum in pregnant patients with coccidioidomycosis
Arsura, E. L., Kilgore, W. B., & Ratnayake, S. N. (1998) · Clinical Infectious Diseases · doi:10.1086/514985 · Cited by 40
McDonald, R., Dufort, E., Jackson, B. R., Tobin, E. H., Newman, A., Benedict, K., & Blog, D. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6738a8 · Cited by 40
Merkhofer, R. M., O’Neill, M. B., Xiong, D., Hernandez-Santos, N., Dobson, H., Fites, J. S., Shockey, A. C., Wuethrich, M., Pepperell, C. S., & Klein, B. S. (2019) · mBio · doi:10.1128/mbio.01224-19 · Cited by 39 · cited 5×
“Defects in the CARD9 pathway have been found predisposing to chronic mucocutaneous candidiasis [28] and disseminated aspergillosis [29], while polymorphisms in a number of cytokines have also been found to predispose to fungal disease: aspergillosis (IL-1 [30], IL-10 [31,32], IL-15 [32], and IL-23); candidiasis (IL-4)…”
BackgroundInfluentialInterferon-gamma and interleukin-4 single nucleotide gene polymorphisms in Paracoccidioidomycosis
Bozzi, A., Reis, B. S., Pereira, P., Pedroso, E. P., & Goes, A. M. (2009) · Cytokine · doi:10.1016/j.cyto.2009.07.011 · Cited by 37
(2014) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000508 · Cited by 36
Recent admixture between species of the fungal pathogen Histoplasma
Maxwell, C. S., Sepulveda, V. E., Turissini, D. A., Goldman, W. E., & Matute, D. R. (2018) · Evolution Letters · doi:10.1002/evl3.59 · Cited by 35
Rising to the challenge of multiple Cryptococcus species and the diseases they cause
Idnurm, A., & Lin, X. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.05.002 · Cited by 34
Rates and risk factors for Coccidioidomycosis among prison inmates, California, USA, 2011
Wheeler, C., Lucas, K. D., & Mohle-Boetani, J. C. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2101.140836 · Cited by 34
Increased Incidence of Rhino-Orbital-Cerebral Mucormycosis After Colorado Flooding
Davies, B. W., Smith, J. M., Hink, E. M., & Durairaj, V. D. (2017) · Ophthalmic Plastic & Reconstructive Surgery · doi:10.1097/iop.0000000000000448 · Cited by 31 · cited 1×
“Outbreaks of mucormycosis outside of India are often associated with natural disasters [90] such as hurricanes [91,92], tsunamis [91], or floodings [93], primarily affecting socially disadvantaged populations living in affected areas.”
BackgroundCoccidioidomycosis in Tulare County, California, 1991: reemergence of an endemic disease
Durry, E., Pappagianis, D., Werner, S. B., Hutwagner, L., Sun, R. K., Maurer, M., McNeil, M. M., & Pinner, R. W. (1997) · Medical Mycology · doi:10.1080/02681219780001361 · Cited by 31
Conneely, S. E., McAtee, C. L., Gupta, R., Lubega, J., Scheurer, M. E., & Rau, R. E. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004735 · Cited by 31 · cited 1×
“Significant racial and ethnic disparities in the incidence and survival of hematologic malignancies have also been documented [51,52].”
BackgroundBlastomycosis Surveillance in 5 States, United States, 1987–2018
Benedict, K., Gibbons-Burgener, S., Kocharian, A., Ireland, M., Rothfeldt, L., Christophe, N., Signs, K., & Jackson, B. R. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2704.204078 · Cited by 29
Taking action to advance the study of race and ethnicity: the Women’s Health Initiative (WHI).
Garcia, L., Follis, S., Thomson, C. A., Breathett, K., Cené, C. W., Jimenez, M., Kooperberg, C., Masaki, K., Paskett, E. D., Pettinger, M., et al. (2022) · Women's Midlife Health · doi:10.1186/s40695-021-00071-6 · Cited by 29 · cited 1×
“Race and ethnicity are socially constructed terms without a biological basis in the scientific literature [5,56].”
BackgroundAspergillus fumigatus Cell Wall Promotes Apical Airway Epithelial Recruitment of Human Neutrophils
Feldman, M. B., Dutko, R. A., Wood, M. A., Ward, R., Leung, H. M., Snow, R. F., Flor, D. J. D. L., Yonker, L. M., Reedy, J. L., Tearney, G. J., et al. (2019) · Infection and Immunity · doi:10.1128/iai.00813-19 · Cited by 29 · cited 1×
“Neutrophils are well known for their role in providing protection against invading fungal pathogens and their recruitment is dependent upon chemokine release [26], and polymorphisms resulting in CXCL10 expression changes have been found associated with aspergillosis [27].”
BackgroundHospitalizations associated with disseminated coccidioidomycosis, Arizona and California, USA
Seitz, A. E., Prevots, D. R., & Holland, S. M. (2012) · Emerging Infectious Diseases · doi:10.3201/eid1809.120151 · Cited by 27
Endogenous Candida endophthalmitis: Who is really at risk?
Seidelman, J., Fleece, M., Bloom, A., Lydon, E., Yang, W., Arnold, C., Weber, D. J., & Okeke, N. L. (2021) · Journal of Infection · doi:10.1016/j.jinf.2020.12.032 · Cited by 26
Gray, G. C., Fogle, E. F., & Albright, K. L. (1998) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1998.58.309 · Cited by 22
Forsythe, A., Vogan, A. A., & Xu, J. (2016) · Scientific Reports · doi:10.1038/srep33828 · Cited by 21
The Changing Epidemiology of Coccidioidomycosis in Los Angeles (LA) County, California, 1973–2011.
Guevara, R. E., Motala, T., & Terashita, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136753 · Cited by 18
Smith, A., & Laribi, O. (2022) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-020-00949-7 · Cited by 18
Wheeler, C., Lucas, K. D., Derado, G., McCotter, O., Tharratt, R. S., Chiller, T., & Mohle-Boetani, J. C. (2018) · Journal of Correctional Health Care · doi:10.1177/1078345818792679 · Cited by 17
Vedula, R. S., Cheng, M. P., Ronayne, C. E., Farmakiotis, D., Ho, V. T., Koo, S., Marty, F. M., Lindsley, R. C., & Bold, T. D. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002854 · Cited by 17
Decreasing Incidence of Disseminated Coccidioidomycosis Among Piman and San Carlos Apache Indians
Sievers, M. L., & Fisher, J. R. (1982) · Chest · doi:10.1378/chest.82.4.455 · Cited by 16
Prostate cancer and the social construct of race
Brawley, O. W. (2021) · Cancer · doi:10.1002/cncr.33417 · Cited by 15
Coccidioidomycosis Among American Indians and Alaska Natives, 2001–2014
McCotter, O., Kennedy, J., McCollum, J., Bartholomew, M., Iralu, J., Jackson, B. R., Haberling, D., & Benedict, K. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz052 · Cited by 14
Xian, Z., Saxena, A., Javed, Z., Jordan, J. E., Alkarawi, S., Khan, S. U., Shah, K., Vahidy, F., Nasir, K., & Dubey, P. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048006 · Cited by 14
Effect of Geography on the Analysis of Coccidioidomycosis-Associated Deaths,. United States
Noble, J. A., Nelson, R. G., Fufaa, G. D., Kang, P., Shafir, S. C., & Galgiani, J. N. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2210.160696 · Cited by 13
Bhatt, M., Porterfield, J. Z., Ribes, J. A., Arora, V., & Myint, T. (2021) · Mycoses · doi:10.1111/myc.13323 · Cited by 13
Racial Differences in Clinical Phenotype and Hospitalization of Blastomycosis Patients.
Anderson, J. L., Frost, H. M., King, J. P., & Meece, J. K. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz438 · Cited by 12
Lee, L. A., Yuan, J., Vugia, D., Wheeler, C., Chapnick, R., & Mohle-Boetani, J. (2017) · Journal of Correctional Health Care · doi:10.1177/1078345817716451 · Cited by 11
Xu, J. J., Chen, J. T., Belin, T. R., et al. (2021) · medRxiv · doi:10.1101/2021.01.28.21249411 · Cited by 11
Bao, F., Fu, X., Yu, G., Wang, Z., Liu, H., & Zhang, F. (2019) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.19-0470 · Cited by 7
Genetic Variation and Fungal Infection Risk: State of the Art
Lionakis, M. S. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00362-6 · Cited by 7 · cited 1×
“These pathways are highly conserved; however, medicationinduced complement defects have been associated with IA [10].”
BackgroundWhen disaster strikes fungi take control
Hoenigl, M. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00268-5 · Cited by 7 · cited 1×
“Outbreaks of mucormycosis outside of India are often associated with natural disasters [90] such as hurricanes [91,92], tsunamis [91], or floodings [93], primarily affecting socially disadvantaged populations living in affected areas.”
BackgroundSelf-citationCoccidioidomycosis infection in a predominantly Hispanic population
PENA‐RUIZ, M. A., MEZA, A. D., & MULLA, Z. D. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1406.038 · Cited by 6
Jaen, G., Drowos, J., Hennekens, C. H., & Levine, R. S. (2020) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-019-00640-6 · Cited by 1
Research works printed but not linked: 2
- RC Lewontin, 1972, Evolutionary Biology.
- Centers for Disease Control and Prevention, Diagnosis of HIV Infection in the United States and dependent areas, 2019, HIV Surveillance Report, 2021, 32
Cited by
Lass-Flörl, C., Kanj, S. S., Govender, N. P., Thompson, G. R., Ostrosky- Zeichner, L., & Govrins, M. A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00503-3 · Cited by 298
Self-citationImpact of climate change and natural disasters on fungal infections
Seidel, D., Wurster, S., Jenks, J. D., Sati, H., Gangneux, J.-P., Egger, M., Alastruey-Izquierdo, A., Ford, N. P., Chowdhary, A., Sprute, R., et al. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(24)00039-9 · Cited by 237
Self-citationHoenigl, M., Arastehfar, A. A., Arendrup, M. C., Brüggemann, R. J. M., Carvalho, A., Chiller, T. M., Chen, W., Egger, M., Feys, S., Gangneux, J., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-23 · Cited by 185
Self-citationFungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management
Thompson, G. R., Jenks, J. D., Baddley, J. W., Lewis, J. S., Egger, M., Schwartz, I. S., Boyer, J., Patterson, T. F., Chen, S. C. ‐., Pappas, P. G., et al. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-23 · Cited by 165
Self-citationEpidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
Self-citation
Metadata
- Authors
- Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R.
- Affiliations
- Duke University (US)
- University of Nigeria (NG)
- Medical University of Graz (AT)
- University of California San Diego (US)
- University of California Davis Medical Center (US)
- Corresponding author
- Jenks, Jeffrey D.
- Hoenigl, Martin
- ORCID
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2023-01-05
- Volume
- 19
- Issue
- 1
- Pages
- e1011025
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC9815636
- OpenAlex
- W4313535151
- Cited by
- 55
- References
- 179
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 21 · 2023: 8
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Pfizer
- Gilead Sciences
- Cidara Therapeutics
- Amplyx
- Astellas Pharma
- Shionogi
- Merck Sharp and Dohme
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Social Sciences › Anthropology › Race, Genetics, and Society
- Keywords
- race and ethnicity, fungal infection, invasive fungal infections, aspergillosis, candidiasis, cryptococcosis, coccidioidomycosis, social determinants of health, health disparities, health care access, host immune response, genetic polymorphism, epigenomics, environmental exposure, endemic fungi
- MeSH terms
- Ethnicity, Hispanic or Latino, Humans, Mycoses, Risk Factors, Socioeconomic Factors, United States, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
